Malignant priapism secondary to osteogenic sarcoma

Nerli, Rajendra B; Koura, Aaryan; Prabha, Vikram; Alur, S S; Devaraju, Sumanth; Godhi, Satyajit; Hiremath, Murigendra B

doi:10.4103/0019-509x.76628

Cited by 7 publications

(7 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1,5 CML accounts 50% of haematological condition causes ischaemic priapism. 2,7 In our series, among 126 patients, we found 6 case of priapism is due to CML and it accounts only around 4% of total; which is similar with world-wide above findings. As, Ischemic Priapism due to CML is a urological emergency, it needs urgent multi-disciplinary intervention required within 4-6 hours to prevent erectile dysfunction.…”

Section: Discussionsupporting

confidence: 90%

Management of Priapism with Chronic Myeloid Lukaemia- A Rare Presentation and Our Experiences

Chowdhury¹,

Al-Asad²,

Rahman³

et al. 2020

Haematol J Bangladesh

View full text Add to dashboard Cite

Background: Ischaemic priapism is one of rare presentation of Chronic myeloid leukaemia due hyper viscosity and it needs urgent urological intervention. Objective: To evaluate the need of urological intervention in Priapism with Chronic Myeloid Leukaemia (CML). Methodology: This is a retrospective study from January 2014 to July 2019 in the department of Urology, DMCH. Among 126 patients 6 were diagnosed as Priapism with CML. Records of these patients were evaluated and analyzed. Results: Among 126 patients 6 patients were diagnosed as priapism with CML Mean age of the patient was 46.7 years, 2 of them were farmer and 2 had history of taking herbal drugs immediate before sexual intercourse and developed Priapism. Five patients were newly diagnosed as CML after admission in Urology ward. Of these six cases five were managed with minimal invasive procedure such as intermittent pseudo-ephedrine injection and wide bore needle corporal aspiration with pseudo-ephedrine irrigation as emergency management, only one needed surgery that was proximal shunt. After emergency management all patients were sent to hematologist for definite management of CML. Conclusion: Priapism with CML is a medical emergency which need immediate minimal intervention with concomitant haematological management.

show abstract

Section: Discussionsupporting

confidence: 90%

Management of Priapism with Chronic Myeloid Lukaemia- A Rare Presentation and Our Experiences

Chowdhury¹,

Al-Asad²,

Rahman³

et al. 2020

Haematol J Bangladesh

View full text Add to dashboard Cite

show abstract

“…Priapism secondary to penile metastasis is rare and one of the etiological factors. 4 Depending on the case series, priapism is seen in between 1 and 5% of male patients with all types of leukemia. 2 Of this small overall percentage, chronic myeloid leukemia (CML) accounts for 50% of all leukemic priapisms.…”

Section: Discussionmentioning

confidence: 99%

Priapism – A Rare Presentation in Chronic Myeloid Leukemia: Case Report

Nerli

Magdum

Hiremath

et al. 2016

Urology Case Reports

View full text Add to dashboard Cite

Priapism is a complication rarely seen in leukemia. We report a 19-year-old man presented with persistent painful erection of penis for over 24 hours at home. The patient had underwent immediate irrigation and decompression of priapism by urologist at emergency services of the hospital. This approach resulted in a flaccid penis later. During hospitalization, peripheral blood smear and bone marrow aspiration confirmed the diagnosis of chronic myeloid leukemia.

show abstract

“…Pelvic malignancies account for the majority of the primary sites for penile metastases, predominantly bladder cancer and prostate cancer accounting for almost two-thirds of the cases 49 followed by colorectal cancers accounting for 19% of the pelvic primaries. 8 Extra-pelvic tumours have also been reported in the kidneys, 49 testes, 29,35 lung, 50 pancreas, 51 oesophagus, 52 melanoma, 53 osteogenic sarcoma 54 and sacrococcygeal chondroma. 30…”

Section: Discussionmentioning

confidence: 99%

“…The acute management of malignant priapism as an ischaemic event with phenylephrine or shunting procedures usually fails to manage the patient’s symptoms or improve the patient’s prognosis. 2,28,54 Multiple modalities of management described in the literature for treatment of penile metastases, including total or partial penectomy, radiotherapy or chemotherapy, have not shown dramatic improvement in patients’ prognoses. 50 In view of the poor prognosis of most patients and the reported mortality of 80% in six months, the management plans should be directed towards improving patients’ quality of life and symptomatic relief.…”

Section: Discussionmentioning

confidence: 99%

Malignant priapism: Review of the report in three decades

Hosny

Nosseir

Pearce

2020

Journal of Clinical Urology

View full text Add to dashboard Cite

Introduction: Priapism is one of the few critical male urological emergencies. There are two main types of priapism, low flow/venous and high flow/arterial priapism. Malignant priapism is a rare subtype of low flow priapism usually secondary to pelvic malignancy, but other extra-pelvic primary cancers cannot be completely excluded. Aim: To assess and highlight the poor prognosis of malignant priapism, with a view to directing management towards both symptomatic relief and improving patients’ quality of life. Method: All reports of malignant priapism between 1998 and 2018 were searched and assessed focusing on the primary cancer, duration of complaint, associated symptoms, method of management and prognosis. Conclusion: Malignant priapism is a rare form of ischaemic priapism, resistant to successful therapies utilized in the management of other forms of ischaemic priapism. Urological cancers are the most common primaries implicated with the most commonly associated symptoms being pain and urinary symptoms. In the absence of any evidence based guidelines and reliably successful treatment options, clinicians should aim to employ supportive treatment strategies including adequate analgesia. Level of evidence: level4

show abstract

Malignant priapism secondary to osteogenic sarcoma

Cited by 7 publications

References 4 publications

Management of Priapism with Chronic Myeloid Lukaemia- A Rare Presentation and Our Experiences

Management of Priapism with Chronic Myeloid Lukaemia- A Rare Presentation and Our Experiences

Priapism – A Rare Presentation in Chronic Myeloid Leukemia: Case Report

Malignant priapism: Review of the report in three decades

Contact Info

Product

Resources

About